EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF)

Fatima Tahir iD, Hossai Gul, Sacha Bossina iD, Fatima Rezae iD, David Martens iD, Helene Rickard, Ayano Kelly

International Journal of Rheumatic Diseases · 2026-11 · 29 (11)

DOI: 10.1111/1756-185x.70928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 29.10.2026. Verfasst von Fatima Tahir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Liverpool Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Gout, Medication Adherence, Gout Suppressants, Patient Care Team. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Royal Australasian College of Physicians (RACP) Research Establishment Fellowship, Sydney Partnership of Health, Education, Research and Enterprise (SPHERE), Implementation Science Platform Grant, Royal Australasian College of Physicians.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Adherence rates to urate lowering therapy in gout remain low. Successfully implemented in Switzerland, the Interprofessional Medication Adherence Program (IMAP) supports medication adherence through an ambulatory‐based model of care that includes pharmacists, motivational interviewing, and electronic adherence monitoring. We aimed to determine the facilitators and barriers to implementing IMAP for patients with gout in a hospital in Australia.

Methods

Multi‐stakeholder, semi‐structured interviews were analyzed using the Theoretical Domains Framework (TDF) for each stakeholder group and Implementation Mapping was used to identify target behaviors.

Results

A total of 51 interviews were conducted with patients ( n = 8), a general practitioner ( n = 1), pharmacists ( n = 8), rheumatologists ( n = 21), nurses ( n = 4), and decision/policy makers ( n = 9). Patients identified their health—reducing gout flares and improving function—as key facilitators, while barriers included environmental context and resources, such as time constraints. Pharmacists and nurses were motivated by professional role and identity, particularly the opportunity to extend their skillsets. However, pharmacists faced barriers related to environmental context and resources, including insufficient funding or managerial support. Nurses were keen to improve their knowledge and skills, such as training in motivational interviewing. Rheumatologists were driven by their goals of improving patient outcomes, but expressed concerns about ensuring governance over a pharmacist‐led program. For general practitioners, behaviors were facilitated by environmental context and resources, such as remuneration. Finally, decision/policy makers identified improving health system outcomes as key enablers, but emphasized the importance of program reach and cost‐effectiveness.

Conclusion

For successful implementation within our context, IMAP‐Gout needs to be adapted from a pharmacist‐led model to a nurse‐led model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoutMedication AdherenceGout SuppressantsPatient Care TeamHumansAdherence InterventionsFemaleHealth Knowledge, Attitudes, PracticePharmacistsMaleAttitude of Health PersonnelMiddle AgedMotivational InterviewingProfessional RoleAgedGeneral PractitionersInterviews as TopicProgram DevelopmentRheumatologistsProgram EvaluationNursesCooperative BehaviorInterdisciplinary Communication

Stichwörter der Autor:innen

goutimplementation sciencemedication adherence

Substanzen

Gout Suppressants

Autor:innen und Institutionen

  • Rheumatology Department, Liverpool Hospital, Sydney, New South Wales, Australia.
  • School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.
  • South West Sydney Campuses, School of Clinical Medicine, UNSW Medicine & Health, Sydney, New South Wales, Australia.
  • Transdisciplinary School, University of Technology, Sydney, New South Wales, Australia.
  • Liverpool Physiotherapy Department, SWSLHD, Liverpool, New South Wales, Australia.
  • School of Pharmacy, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Fatima Tahir, Sacha Bossina, Fatima Rezae, David Martens

Förderung

  • Royal Australasian College of Physicians (RACP) Research Establishment Fellowship
  • Sydney Partnership of Health, Education, Research and Enterprise (SPHERE), Implementation Science Platform Grant
  • Royal Australasian College of Physicians

Zitieren

APA

Tahir, F., Gul, H., Bossina, S., Rezae, F., Martens, D., Rickard, H., & Kelly, A. (2026). Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF). International Journal of Rheumatic Diseases, 29(11). https://doi.org/10.1111/1756-185x.70928

Vancouver

Tahir F, Gul H, Bossina S, Rezae F, Martens D, Rickard H, et al. Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF). International Journal of Rheumatic Diseases. 2026;29(11). doi:10.1111/1756-185x.70928

BibTeX
@article{Tahir2026,
  author = {Tahir, Fatima and Gul, Hossai and Bossina, Sacha and Rezae, Fatima and Martens, David and Rickard, Helene and Kelly, Ayano},
  title = {Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF)},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {11},
  doi = {10.1111/1756-185x.70928}
}
Kostenlos starten →